Navigation Links
Does Your Business Have the Tools to Compete in the World's Largest Diagnostics Markets?
Date:10/30/2013

MOUNTAIN VIEW, Calif., Oct. 30, 2013 /PRNewswire/ -- The inclusive and increasingly competitive in vitro diagnostics (IVD) landscape is evolving in unison with healthcare reform. Therefore, it is vital for all market participants to understand the transformation and manage amidst the changes.  Those even remotely invested in the market require crucial insight on business strategy and regulatory and technological advancements essential for success, in addition to current and future growth trends and market opportunities that will keep them a key player.

"Global IVD companies have been forced to adjust to a lower healthcare spending baseline for what is currently the world's largest IVD market, the United States," said Frost & Sullivan Life Sciences Senior Industry Analyst Winny Tan. "We used to describe the diagnostics market as highly cost-sensitive; now it is the entire healthcare industry that is cost-constrained. Competing in this business environment means growth strategies need to deliver the greatest value with low upfront investments. Potential strategies that fit a cost-constrained industry include identifying underpenetrated markets, leveraging external innovation partners and taking advantage of existing data."

To evaluate these strategies, Tan participates in IVD Business Strategy Conference (http://www.ivdtconference.com/), taking place Nov. 6-8, 2013, in San Diego, Calif.  Her presentation, "Evaluating Diagnostic Industry Growth Trends and Market Opportunities in Global Markets," is on day one of the event and will provide a competitive overview through an analysis of the global IVD market; an evaluation of market revenue opportunities, segment sizes and growth rates; and an assessment of emerging IVD markets.

IVD Business Strategy Conference 2013 provides a full scope view of the business strategy, regulatory and technology advancements essential to generating success in the IVD marketplace.  The event will feature real world case studies by providers as well as a half-day supplemental workshop on reimbursement strategies facilitated by Emerson Consulting.

This all-inclusive two-day conference program covers a range of topics to develop and successfully commercialize in vitro diagnostics, including what's to come for the IVD business landscape and identifying domestic and global growth trends and opportunities; pinpointing regulatory submission requirements for the U.S., Europe, and emerging markets and determining the best documentation approach for speed to market; applying the latest technology in sequencing, molecular diagnostics, wireless, and point of care devices to enhance your IVD product portfolio; and tackling challenges in regulatory approval, pricing, co-development, and relationship management when developing a companion diagnostic.

The conference is suited for IVD manufacturers looking for key regulatory, business and technical updates, as well as pharmaceutical companies looking to enter the personalized medicine arena. All top-level professionals from the following functions will benefit: companion diagnostics, personalized medicine, research and development, business development, manufacturing, regulatory affairs, innovation, pipeline/portfolio, and planning and project management.

The partnership with IVD Business Strategy Conference is part of Frost & Sullivan's Life Sciences Growth Partnership Service program.  Connect with us on social media, including Twitter, Facebook, SlideShare, and LinkedIn, for the latest news and updates.

About MD+DI
Medical Device + Diagnostic Industry (MD+DI) is a magazine and information resource exclusively for original equipment manufacturers of medical devices and in vitro diagnostic products. For more than 30 years, MD+DI has been the leading industry source of in-depth news and information to help industry professionals develop, design and manufacture medical products that comply with complex and demanding regulations and market requirements. Please visit www.mddionline.com for more information.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Contact:
Jennifer Carson
Corporate Communications – North America
P: 210.247.2450
F: 210.348.1003
E: jennifer.carson@frost.com
Twitter: @Frost_Sullivan
Facebook: Frost & Sullivan

http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Turkey Businessman, Two Years Without a Human Heart, Goes Four-Wheeling
2. Anti-Adhesion Products - Global Strategic Business Report
3. Global Strategic Business Radiopharmaceuticals Report 2013-2018: High Costs of Drug Development Piques Manufacturers
4. Dental Restorative Supplies - Global Strategic Business Report - 2013-2018
5. University of Miami Program To Train Health Care Executives on Tackling Ethical and Compliance Issues When Doing Business in Latin America
6. Medbox CEO Featured on FOX Business Network
7. GlySure Wins 2013 Small Business of the Year and New Product of the Year
8. Dental Prosthetic Supplies - Global Strategic Business Report 2013-2018 - Aging Global Population is a Major Growth Propeller
9. Indivumed Sells Inostics, the plasma-DNA Company, to Sysmex and Expands its Clinical Research Service and Patient Diagnostics Business
10. MabVax Therapeutics Receives $1,750,000 Small Business Innovation Research Contract Award From The National Cancer Institute To Support Development of Novel Pancreatic Cancer Diagnostic Imaging Agent
11. Actinium Pharmaceuticals Appoints Corey Sohmer As Vice President Of Finance And Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... 11, 2017  BioPharmX Corporation (NYSE MKT: BPMX) researchers ... an innovative way to use nonlinear optical imaging to ... new drugs. ... will show how researchers from BioPharmX and the Wellman ... used a suite of imaging techniques in what is ...
(Date:10/11/2017)...  True Health, a leader in integrated diagnostics ... National Breast Cancer Awareness month to educate doctors ... Research recently published in ... than 10 million American women are at significant ... BRCA2 and have not had testing. These mutations can ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017  NDS received FDA 510(k) ... — a medical-grade battery-powered display stand specifically designed for endoscopy environments. ... transform technology into a clinical solution to support the improvement of ... Innovative Design ... Mobile Wireless Solution ...
Breaking Medicine Technology:
(Date:10/13/2017)... Pekin, IL (PRWEB) , ... October 13, 2017 ... ... Foundation, which established the certification process to promote standards of excellence for the ... iaedp™ Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... , ... Talented host, actor Rob Lowe, is introducing a ... episode of "Success Files," which is an award-winning educational program broadcasted on PBS ... in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve in ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
Breaking Medicine News(10 mins):